Short Interest in Poxel S.A. (OTCMKTS:PXXLF) Expands By 9,300.0%

Poxel S.A. (OTCMKTS:PXXLF) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 9,400 shares, a growth of 9,300.0% from the January 31st total of 100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Poxel Stock Performance

Shares of Poxel stock opened at $0.25 on Friday. Poxel has a 1 year low of $0.25 and a 1 year high of $0.25. The company has a 50 day simple moving average of $0.25 and a two-hundred day simple moving average of $0.49.

Poxel Company Profile

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.